← Back to Search

Brachytherapy

Low Dose Radiation Focal Brachytherapy for Prostate Cancer (FTPC Trial)

N/A
Waitlist Available
Led By William J Morris, MD
Research Sponsored by British Columbia Cancer Agency
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 4 years; upon study completion
Awards & highlights

Summary

This project will develop and evaluate a treatment plan for prostate focal therapy based on low dose rate brachytherapy. The participants entering this study are those suitable for active surveillance. These participants will be monitored with various imaging methods and interventions such as MR elastography, Transrectal ultrasound elastography, PET/CT and transperineal mapping biopsy to determine the extent of cancer and suitable treatments. Those suitable for focal therapy will be offered the option of low dose rate brachytherapy (LDRB) focal therapy in addition to active surveillance or radical therapy. This study will be used to evaluate the long term use of multi-modal, multi-parametric prostate cancer imaging, combining data from MRI, ultrasound and 11C-choline PET/CT. Such methods can be used to eliminate the need for invasive methods such as mapping biopsies.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 4 years; upon study completion
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 4 years; upon study completion for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Constitute Disease Criteria and Appropriate Treatment Plans
Secondary study objectives
Quality of Life
Other study objectives
Prune Belly Syndrome

Trial Design

1Treatment groups
Experimental Treatment
Group I: Low Dose Radiation Focal BrachytherapyExperimental Treatment1 Intervention
Low Dose Radiation Focal Brachytherapy

Find a Location

Who is running the clinical trial?

British Columbia Cancer AgencyLead Sponsor
172 Previous Clinical Trials
90,594 Total Patients Enrolled
23 Trials studying Prostate Cancer
5,802 Patients Enrolled for Prostate Cancer
William J Morris, MDPrincipal InvestigatorBritish Columbia Cancer Agency
4 Previous Clinical Trials
495 Total Patients Enrolled
4 Trials studying Prostate Cancer
495 Patients Enrolled for Prostate Cancer
~1 spots leftby Sep 2025